Provided herein is a process for forming a 3D object on a substrate using liquid inkjet compositions, machinery and methodologies, devoid of dry powders or UV-curable agents. The 3D object is digitally printed according to the additive approach, by inkjet printing a top layer over a base layer before curing the base layer, whereas a layer is formed as a gel, and the gelatinous object is thereafter cured.

A molded article 1 is made of a resin material 3 containing cellulose fibers 2. The molded article 1 has a surface portion 4 that is in a range satisfying T.sub.F0.1T where T is the thickness of the molded article 1 and T.sub.F is a distance from the surface of the molded article 1, and the molded article 1 satisfies D.sub.F1.1D where D is an average cellulose concentration of the overall molded article 1 and D.sub.F is an average cellulose concentration of the surface portion 4. Thus, the molded article suppresses an increase in bending modulus while considerably improving a tensile modulus.

The present invention relates to the treatment or prevention of skeletal disorders, in particular skeletal diseases, developed by patients that display abnormal increased activation of the fibroblast growth factor receptor 3 (FGFR3), in particular by expression of a constitutively activated mutant of FGFR3.

A composite product comprising a fibrous material (A) and a polymer material (B), wherein the composite product is formed as a sheet, by wet web formation and wherein said web is formed from a suspension of said fibrous material and said polymer material in a double wire press (2a and 2b).

The present invention relates to the treatment or prevention of skeletal disorders, in particular skeletal diseases, developed by patients that display abnormal increased activation of the fibroblast growth factor receptor 3 (FGFR3), in particular by expression of a constitutively activated mutant of FGFR3.

A molded article consisting of an organic compound, preferably cellulose fibers having a glass transition point above 200 C and melt blended with thermoplastic polymers of different melt temperatures, whereby, a 3 or 4 Dimensional printer that may consist of an additional 5 or 6 axis, has cellulose fiber particles that are layered and compressible in a semi solid state. These layers having non oriented cellulose fiber particles will help produce a buoyant molded article with a surface texture that can absorb moisture and attract gases for coatings.

The invention relates to an acoustic product composed of composite material, such as a musical musical instrument, a part thereof, an acoustic equipment or like, which is manufactured from raw material comprising at least cellulose based substance and plastic based substance by means of a thermoplastic process, such as by pressing, compression molding, injection molding, extrusion, blow molding by heat, rotational molding and/or the like. The acoustic product has a material composition consisting of fiber substance (1) based on surface modified cellulose and plastic based substance (2), wherein the product has an essentially wood-like, but isotropic sound.

A composite material panel includes a substrate formed of a first material; one or more strands formed from a second material, the strands being interspersed through the substrate, the second material being a natural material, the second material providing modified mechanical properties of the composite material panel.

In a method for controlling shrinkage of a composite, a dried hydrophobically modified cellulose-based fiber is exposed to a slow acting resin system having a first curing time. An excess amount of the slow acting resin system is removed to separate out the pre-wetted hydrophobically modified cellulose-based fiber. The pre-wetted hydrophobically modified cellulose-based fiber is mixed with a fast acting resin system to form a mixture. The fast acting resin system has a second curing time that is less than the first curing time. The mixture is molded at a predetermined temperature. The fast acting resin system is cured prior to the slow acting resin system, and the slow acting resin system flows into free space within the curing fast acting resin system prior to the slow acting resin system being cured.

The present invention relates to the treatment or prevention of skeletal disorders, in particular skeletal diseases, developed by patients that display abnormal increased activation of the fibroblast growth factor receptor 3 (FGFR3), in particular by expression of a constitutively activated mutant of FGFR3.